GREAT-SUN(SH:603336) Sou Hu Cai Jing·2025-06-17 01:33Core Viewpoint - The recent equity transfer of Honghui Fruits and Vegetables has resulted in a change of actual controllers to Ye Tao, Liu Yang, and Suzhou State-owned Assets Investment Management Group, raising speculation about potential reverse listing for Ye Tao's pharmaceutical company [2][3][5]. Group 1: Equity Transfer Details - On June 13, Honghui Fruits and Vegetables announced the completion of an equity transfer, with Huang Junhui transferring 151 million shares (26.54% of total shares) to Suzhou Shenze Ruitai Enterprise Management Partnership for a total price of RMB 860 million at RMB 5.68 per share [2][3]. - Following the transfer, Shenze Ruitai becomes the controlling shareholder of Honghui Fruits and Vegetables [3]. Group 2: Company Performance - Honghui Fruits and Vegetables has experienced declining performance, with 2024 revenue at RMB 1.08 billion, down 52% year-on-year, and a net profit of RMB 18 million, down 23.59% [5][6]. - In Q1 2024, the company reported revenue of RMB 246 million, a 13.71% increase year-on-year, but a net profit decline of 44.38% [5][6]. Group 3: Background of New Controllers - Ye Tao, one of the new controllers, is linked to a pharmaceutical company, Teng Rui Pharmaceutical, which previously sought to go public in 2021 [7][11]. - Teng Rui Pharmaceutical, established in 2010, focuses on drug research, production, and marketing, with one product already on the market and another in clinical trials [9][11]. Group 4: Market Reaction - Following the announcement of the equity transfer, Honghui Fruits and Vegetables' stock price rose to RMB 6.85, marking a 9.78% increase, although it initially dropped before recovering [11].